Finch Therapeutics Group Statistics
Total Valuation
FNCH has a market cap or net worth of $3.21 million. The enterprise value is $12.01 million.
Market Cap | 3.21M |
Enterprise Value | 12.01M |
Important Dates
The last earnings date was Friday, May 10, 2024, before market open.
Earnings Date | May 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
FNCH has 1.61 million shares outstanding. The number of shares has increased by 0.18% in one year.
Shares Outstanding | 1.61M |
Shares Change (YoY) | +0.18% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 53.48% |
Owned by Institutions (%) | 11.35% |
Float | 792,862 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.17 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.05, with a Debt / Equity ratio of 1.55.
Current Ratio | 6.05 |
Quick Ratio | n/a |
Debt / Equity | 1.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 12.43 |
Financial Efficiency
Return on equity (ROE) is -68.10% and return on invested capital (ROIC) is -47.89%.
Return on Equity (ROE) | -68.10% |
Return on Assets (ROA) | -28.10% |
Return on Capital (ROIC) | -47.89% |
Revenue Per Employee | n/a |
Profits Per Employee | -$16.28M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.98% in the last 52 weeks. The beta is 0.46, so FNCH's price volatility has been lower than the market average.
Beta (1Y) | 0.46 |
52-Week Price Change | -80.98% |
50-Day Moving Average | 2.41 |
200-Day Moving Average | 3.79 |
Relative Strength Index (RSI) | 42.23 |
Average Volume (30 Days) | 52,908 |
Short Selling Information
The latest short interest is 26,349, so 1.64% of the outstanding shares have been sold short.
Short Interest | 26,349 |
Short Previous Month | 10,600 |
Short % of Shares Out | 1.64% |
Short % of Float | 3.32% |
Short Ratio (days to cover) | 0.28 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -23.28M |
Pretax Income | -16.28M |
Net Income | -16.28M |
EBITDA | -14.28M |
EBIT | -17.71M |
Earnings Per Share (EPS) | -$10.14 |
Balance Sheet
The company has $20.76 million in cash and $29.56 million in debt, giving a net cash position of -$8.80 million or -$5.48 per share.
Cash & Cash Equivalents | 20.76M |
Total Debt | 29.56M |
Net Cash | -8.80M |
Net Cash Per Share | -$5.48 |
Equity / Book Value | 19.04M |
Book Value Per Share | 11.86 |
Working Capital | 17.68M |
Cash Flow
In the last 12 months, operating cash flow was -$22.49 million and capital expenditures $1.34 million, giving a free cash flow of -$21.15 million.
Operating Cash Flow | -22.49M |
Capital Expenditures | 1.34M |
Free Cash Flow | -21.15M |
FCF Per Share | -$13.17 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.18% |
Shareholder Yield | -0.18% |
Earnings Yield | -507.02% |
FCF Yield | -658.41% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a reverse split with a ratio of 1:30.
Last Split Date | Jun 12, 2023 |
Split Type | Reverse |
Split Ratio | 1:30 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |